Long-term metastatic melanoma survival dramatically improves on immunotherapy, clinical trial finds - Medical Xpress
- Long-term metastatic melanoma survival dramatically improves on immunotherapy, clinical trial finds Medical Xpress
- Half of advanced melanoma patients live for 10 years with double drug treatment The Guardian
- New skin cancer treatment helps patients live 10 years after diagnosis, study finds The Telegraph
- Immunotherapy Drugs Extend Survival for Patients With Advanced Melanomas U.S. News & World Report
- Neoadjuvant Immunotherapy Superior to Targeted Therapy in Stage III Melanoma AJMC.com Managed Markets Network